Frequency of Elevated Intraocular Pressure in Patients with Acute and Chronic Anterior Uveitis
Main Article Content
Abstract
Background: Elevated intraocular pressure (IOP) is a frequent and serious complication in patients with uveitis, potentially leading to secondary glaucoma and permanent vision loss. Understanding the frequency and associated risk factors of elevated IOP in patients with acute and chronic anterior uveitis is essential for effective management and prevention of visual morbidity.
Objective: This study aimed to determine the frequency of elevated IOP in patients with acute and chronic anterior uveitis and to identify the associated demographic and clinical factors.
Methods: This This descriptive, cross-sectional study was conducted over six months at the Outpatient Department of Al-Shifa Trust Eye Hospital, Rawalpindi, involving 160 patients aged 20 to 60 years diagnosed with anterior uveitis. Patients were excluded if they were on anti-glaucoma medications, had specific ocular conditions, or had a pre-existing diagnosis of glaucoma or elevated IOP. Intraocular pressure was measured using Goldmann Applanation Tonometry, with elevated IOP defined as >21 mmHg. Demographic data and clinical history, including the duration and grade of uveitis, were recorded. Data were analyzed using SPSS version 25, with qualitative variables presented as frequencies and percentages, and statistical significance assessed using chi-square tests (p ≤ 0.05).
Results: The mean age of the study participants was 33.19 years (SD ± 7.26). Elevated IOP was observed in 38.75% of the patients. A significantly higher frequency of elevated IOP was found in females (61.7% vs. 25% in males, p = 0.000), patients over 30 years of age (46.4% vs. 30.3%, p = 0.026), and those with hypertension (69.8% vs. 23.4% in non-hypertensive patients, p = 0.000). Grade I uveitis had the highest frequency of elevated IOP (100%), followed by grade III (42.9%), grade IV (4.1%), and grade II (0%) (p = 0.000). No significant association was found between elevated IOP and diabetes mellitus or the duration of uveitis.
Conclusion: The study found a substantial frequency of elevated IOP in patients with anterior uveitis, particularly among females, older patients, and those with hypertension. These findings highlight the need for regular IOP monitoring and tailored management strategies in high-risk patients to prevent the development of secondary glaucoma and associated vision loss.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Duplechain A, Conrady CD, Patel BC, Baker S. Uveitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Jul 31]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK540993/
Harthan JS, Opitz DL, Fromstein SR, Morettin CE. Diagnosis and Treatment of Anterior Uveitis: Optometric Management. Clin Optom. 2016;8:23–35.
Feroze KB, Zeppieri M, Khazaeni L. Steroid-Induced Glaucoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Jul 31]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK430903/
Kalogeropoulos D, Sung VC. Pathogenesis of Uveitic Glaucoma. J Curr Glaucoma Pract. 2018;12(3):125–38. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647826/
Muñoz-Negrete FJ, Moreno-Montañés J, Hernández-Martínez P, Rebolleda G. Current Approach in the Diagnosis and Management of Uveitic Glaucoma. Biomed Res Int. 2015;2015:742792. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628996/
American Academy of Ophthalmology. Management of Uveitic Glaucoma. [Internet]. 2019 [cited 2024 Jul 31]. Available from: https://www.aao.org/eyenet/article/management-of-uveitic-glaucoma
Zikou AK, Anastasopoulos E, Ioannidis AS, Kitsos G, Balatsoukas D. Visual Outcomes and Ocular Morbidity of Patients With Uveitis Referred to a Tertiary Center During First Year of Follow-Up. Eye (Lond). 2015;29(5):767–72. Available from: https://www.nature.com/articles/eye2015269
Machiele R, Motlagh M, Zeppieri M, Patel BC. Intraocular Pressure. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Jul 31]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK532237/
Friedman DS, Holbrook JT, Ansari H, Alexander J, Burke A, Reed SB, et al. Risk of Elevated Intraocular Pressure and Glaucoma in Patients With Uveitis: Results of the Multicenter Uveitis Steroid Treatment Trial. Ophthalmology. 2013;120(8):1571–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720698/
Abbas I, Ahmed AM, Dayal SM, Sirhindi GA. Frequency of Elevated Intraocular Pressure in Patients With Uveitis. Pak J Med Health Sci. 2023;17(3):1151–5. Available from: https://pjmhsonline.com/published-issues/1151
Ahmed MS, Ullah AY, Barman N, Ratan ZA, Mostafa S, Khaleque A, et al. Risk Factors Associated With Elevated Intraocular Pressure: A Population-Based Study in a Rural Community of Bangladesh. BMJ Open Ophthalmol. 2023;8(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582991/
Pineda-Sierra JS, Cifuentes-González C, Rojas-Carabali W, Muñoz-Vargas PT, Henao-Posada A, De-La-Torre A. Clinical Characterization of Patients With HLA-B27-Associated Uveitis and Evaluation of the Impact of Systemic Treatment on the Recurrence Rate: A Cross-Sectional Study. J Ophthalmic Inflamm Infect. 2023;13(1):38. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468442/
Klein BE, Klein R, Knudtson MD. Intraocular Pressure and Systemic Blood Pressure: Longitudinal Perspective From the Beaver Dam Eye Study. Br J Ophthalmol. 2005;89(3):284–7.
Tiambeng C, Batur A, Dikmetas Ö, Aksu NM. The Acute Effect of Systemic Blood Pressure Reduction on Intraocular Pressure in Hypertensive Patients. Turk J Emerg Med. 2022;22(3):131–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355068/
Mostafizur Rahman M, Rahman MS, Hossain MJ, Rana MM, Rahman M, Ahmed M, et al. Factors Associated With Increased Intraocular Pressure in Type 2 Diabetes Patients. J Clin Med. 2023;13(3):676. Available from: https://www.mdpi.com/2077-0383/13/3/676
Singh VP, Bali A, Singh N, Jaggi AS. Type 2 Diabetes Mellitus, Oxidative Stress and Inflammation: Examining the Links. Curr Diabetes Rev. 2014;10(3):283–93. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628012/
Herbert HM, Viswanathan A, Jackson H, Lightman SL. Risk Factors for Elevated Intraocular Pressure in Uveitis. J Glaucoma. 2004;13(2):96–9.
Rao NA. Grading of Ocular Inflammation in Uveitis: An Overview. Eye News. 2020;27(1):20-23. Available from: https://www.eyenews.uk.com/features/ophthalmology/post/grading-of-ocular-inflammation-in-uveitis-an-overview
Rosenbaum JT, Smith JR, Wells J, Aylward GW, Palmer HE. Uveitis Evaluation and Treatment: Approach to the Uveitis Workup, Choosing the Correct Diagnostic Test, Evidence-Based Medicine Approach to the Diagnosis of Uveitis. Medscape. 2024 Mar 6 [cited 2024 Jul 31]. Available from: https://emedicine.medscape.com/article/1209123-overview
Din NM, Isa H, Taylor SR, Barton K, Lightman SL. Intraocular Pressure Elevation in Uveitis. Expert Rev Ophthalmol. 2012;7(1):45–59. Available from: https://doi.org/10.1586/eop.11.75 Stefanini GG, Holmes DR Jr. Drug-Eluting Coronary-Artery Stents. N Engl J Med. 2013;368(3):254-65.